Share

May 01, 2018; 90 (18) Resident & Fellow Section

Clinical Reasoning: A 22-year-old postpartum woman with new-onset seizures and headache

Kevin McGehrin, Chamindra Konersman, Ronald Ellis
First published April 30, 2018, DOI: https://doi.org/10.1212/WNL.0000000000005414
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1129

Share

Article Information

vol. 90 no. 18 e1631-e1635
DOI: 
https://doi.org/10.1212/WNL.0000000000005414
PubMed: 
29712815
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 30, 2018.
Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Kevin McGehrin, MD,
    2. Chamindra Konersman, MD and
    3. Ronald Ellis, MD, PhD
  1. Kevin McGehrin, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Chamindra Konersman, MD and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Served once as a consultant in 2016 for Sarepta pharmaceuticals (commercial, for-profit). Served once as a consultant for Biogen pharmaceuticals in 2017 (commercial, for-profit).

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Ronald Ellis, MD, PhD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NeurogesX, Inc. - Consultant fee for FDA Advisory panel

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH, P30 MH62512, Co-investigator, 2015-2020 (2) NIH, R01AG04865, Principal Investigator, 2015-2020 (3) NIH, P50DA026306, Co-investigator, 2014-2019 (4) NIH, U24MH100928, Co-investigator, 2013-2018 (5) NIH, R01 MH108466, Co-investigator, 2015-2020 (6) NIH, R01MH107345, Co-investigator, 2015-2020 (7) NIH, P30MH062512, Co-investigator, 2016-2021 (8) NIH, UM1AI068636, Co-investigator, 2016-2017 (9) NIH, R01DA043430, Principal Investigator, 2016-2020 (10) NIH, R21DA041007, Co-investigator, 2015-2018 Stock/Stock Options, Medical Equipment & Materials: Abbott Laboratories, 2016-2017, stock held by spouse Johnson and Johnson, 2016-2017, stock held by spouse ABBVIE, 2016-2017, stock held by spouse Merck and Co. Inc, 2016-2017, stock held by spouse

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurosciences, University of California, San Diego.
  1. Correspondence
    Dr. McGehrin kmcgehrin{at}ucsd.edu
View Full Text

Article usage

Article usage: April 2018 to April 2022

AbstractFullPdfSource
Apr 201805648Highwire
May 20180354634Highwire
Jun 2018011265Highwire
Jul 201806424Highwire
Aug 20180537Highwire
Sep 20180449Highwire
Oct 201804812Highwire
Nov 20180305Highwire
Dec 201804916Highwire
Jan 201914313Highwire
Feb 20194346Highwire
Mar 201902713Highwire
Apr 20192339Highwire
May 20192199Highwire
Jun 20191188Highwire
Jul 201901413Highwire
Aug 20190349Highwire
Sep 2019196Highwire
Oct 20191336Highwire
Nov 201902512Highwire
Dec 201901310Highwire
Jan 20205295Highwire
Feb 20202189Highwire
Mar 202001110Highwire
Apr 20200152Highwire
May 202002316Highwire
Jun 202021812Highwire
Jul 20201138Highwire
Aug 2020084Highwire
Sep 20201120Highwire
Oct 20201123Highwire
Nov 20200168Highwire
Dec 20203222Highwire
Jan 202101210Highwire
Feb 2021073Highwire
Mar 20213257Highwire
Apr 2021095Highwire
May 202112410Highwire
Jun 20211132Highwire
Jul 20210186Highwire
Aug 20211192Highwire
Sep 202111510Highwire
Oct 202111718Highwire
Nov 202101919Highwire
Dec 20211182Highwire
Jan 20220182Highwire
Feb 20220241Highwire
Mar 20220139Highwire
Apr 202213610Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me